Business Description
Samsung Pharmaceutical Co Ltd
ISIN : KR7001360007
Compare
Compare
Traded in other countries / regions
001360.Korea IPO Date
1975-07-04Description
Samsung Pharmaceutical Co Ltd is a South Korea based company engages in the manufacturing, supply, and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides, and healthcare food items.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.83 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.51 | |||||
| Beneish M-Score | -1.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 0.3 | |||||
| 3-Year FCF Growth Rate | -56 | |||||
| 3-Year Book Growth Rate | -16.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.13 | |||||
| 9-Day RSI | 48.56 | |||||
| 14-Day RSI | 48.81 | |||||
| 6-1 Month Momentum % | -2.22 | |||||
| 12-1 Month Momentum % | -22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.08 | |||||
| Quick Ratio | 2.09 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 224.19 | |||||
| Days Sales Outstanding | 49.63 | |||||
| Days Payable | 70.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3 | |||||
| Shareholder Yield % | -28.74 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.8 | |||||
| Operating Margin % | -37.37 | |||||
| Net Margin % | -19.46 | |||||
| FCF Margin % | -42.8 | |||||
| ROE % | -8.87 | |||||
| ROA % | -7.56 | |||||
| ROIC % | -20.11 | |||||
| ROC (Joel Greenblatt) % | -65.71 | |||||
| ROCE % | -24.78 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.82 | |||||
| PB Ratio | 1.21 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| EV-to-EBIT | -4.88 | |||||
| EV-to-EBITDA | -5.29 | |||||
| EV-to-Revenue | 2.72 | |||||
| EV-to-FCF | -6.38 | |||||
| Price-to-Median-PS-Value | 0.76 | |||||
| Price-to-Net-Current-Asset-Value | 4.2 | |||||
| Price-to-Net-Cash | 34.89 | |||||
| Earnings Yield (Greenblatt) % | -20.51 | |||||
| FCF Yield % | -13.5 | |||||
| Forward Rate of Return (Yacktman) % | -49.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Samsung Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 45,847.42 | ||
| EPS (TTM) (â‚©) | -139.207 | ||
| Beta | 0.66 | ||
| Volatility % | 28.01 | ||
| 14-Day RSI | 48.81 | ||
| 14-Day ATR (â‚©) | 51.772745 | ||
| 20-Day SMA (â‚©) | 1537.6 | ||
| 12-1 Month Momentum % | -22 | ||
| 52-Week Range (â‚©) | 1390 - 2705 | ||
| Shares Outstanding (Mil) | 94.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Samsung Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Samsung Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Samsung Pharmaceutical Co Ltd Frequently Asked Questions
What is Samsung Pharmaceutical Co Ltd(XKRX:001360)'s stock price today?
The current price of XKRX:001360 is â‚©1544.00. The 52 week high of XKRX:001360 is â‚©2705.00 and 52 week low is â‚©1390.00.
When is next earnings date of Samsung Pharmaceutical Co Ltd(XKRX:001360)?
The next earnings date of Samsung Pharmaceutical Co Ltd(XKRX:001360) is .
Does Samsung Pharmaceutical Co Ltd(XKRX:001360) pay dividends? If so, how much?
Samsung Pharmaceutical Co Ltd(XKRX:001360) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers